ER-100 was well tolerated through Day 56 in the first 3 patients with open-angle glaucoma, with no dose-limiting toxicities, serious adverse events, or adverse events of special interest reported Two ...
Topcon Healthcare has launched Oku Digital Health, an AI-powered company focused on using ocular data to support disease detection, referrals, and pharmaceutical research Oku combines AI-supported ...
Eyestem reported interim phase 2 findings for Eyecyte-RPE, an investigational RPE cell therapy for GA secondary to dry AMD, with 24 participants enrolled in the randomized controlled study Early ...
Key Takeaways Moorfields Private has introduced specialist eye assessments for patients taking GLP-1 medications, including ...
Key Takeaways Two AAO case reports examine cryopreserved amniotic membrane in neurotrophic keratitis and severe HSV keratitis ...
MyEyeDr. has agreed to acquire EyeCare Partners' optometry division, including more than 300 offices across 5 eye care brands MyEyeDr. said the expanded organization will support greater access to ...
Both Zenkuda and tabirafusp-ted met the phase 3 DAYBREAK primary endpoints, achieving noninferiority to aflibercept for vision gains at 1 year in patients with wet AMD Kodiak reported that 54% of ...
Claris Biotherapeutics will relocate its headquarters from Jersey City, New Jersey, to South San Francisco, California, effective October 2026 The company plans to begin pivotal studies of CSB-001 ...
The Glaucoma Vision Act of 2026 would expand annual glaucoma screening coverage across private insurance, Medicaid, Medicare, and the Federal Employees Health Benefits Program for eligible individuals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results